Fate Therapeutics

In News

Fate Therapeutics Selected for Four Presentations Highlighting its Off-the-Shelf CAR T-Cell Portfolio in Autoimmune Disease at ACR Convergence 2026 - GlobeNewswire

GlobeNewswire - Sep 16, 2026

Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference - Yahoo Finance

Yahoo Finance - Sep 03, 2026

Fate’s off-the-shelf CAR-T therapy shows early promise in treatment-resistant autoimmune disease - fiercebiotech.com

fiercebiotech.com - Jul 09, 2026

Fate Therapeutics: RECLAIM-LN Underway, Additional Clinical Updates Ahead (NASDAQ:FATE) - Seeking Alpha

Seeking Alpha - Sep 02, 2026

Fate Therapeutics Announces Encore Clinical Data - GlobeNewswire

GlobeNewswire - Sep 09, 2026

Fate Therapeutics (FATE) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Yahoo Finance - Aug 13, 2026

Will Fate Therapeutics (NASDAQ:FATE) Spend Its Cash Wisely? - Yahoo Finance

Yahoo Finance - May 30, 2026

H.C. Reiterates “Buy” Rating On Fate Therapeutics (FATE) With $7 PT - Yahoo Finance

Yahoo Finance - Jun 10, 2026

Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate - GlobeNewswire

GlobeNewswire - Jul 09, 2026

Fate Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates - Yahoo Finance

Yahoo Finance - Aug 13, 2026

Fate Therapeutics Appoints Laura Hamill to Board of Directors - Yahoo Finance

Yahoo Finance - Jun 15, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

GlobeNewswire - Aug 03, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment